1.3 Interactions, Agonist & Isomerism Flashcards
Absorprtion
ADME
Charcoal - toxic in pos
Prokinetic - alter GIT
muscarinic - inhib emptying - oppostie
Distrib - CO increase red speec absorb
BBloq - red co sux longer NMJ
COmpeter site - enzyme syst
Phenytoin w/ sulphonamide - displace pheny
Metabolism
Ph 1 Red/ox/hydrol
Cyt p450
Inducers
Rifampicin
Inhib
Cimitideine
Excretion
Change urinary ph
Sod bic - aspirin increase
PD interactions
2 drugs @ / near site action
Direct - same mechanism
Flumazenil rev BZD
Naloxone - opiod
Indeirect - differ
neostigmine - rev NDMR - achesterase inhib
More ach at clef -compete NDMR binding site
Adrenaline - inc cAMP by GpCR
Enox - PDEi - inc CAMP
Indirect increase cAMP improve contractiliy
What is Cytp450
Family protein in Sm ER heaptocytes Mediate Red/Ox Isoform enzyme 7 most improtant in metab CYP3A4 - most
Induce cyp450
Barbiturates Phenytoin Carbamazepine griseofulvin rifampicin
Chronic alcohol
Polycyclic hrdyocarb - tobacco . meats
Brocolli - 1 form
Inhbi cyp450
Imdazole derive - keto con, itra omprea
cimetidine
etomidate -
all by bind w/ haem
Macolride Most anti dipre HIV protease inhib cyclosporine Amio
Grapefruit juice
Summation
Action drugs additive
Premed w/ bzf - then prop
Dose to achieve anaesethesia lower
Synergism
Combined action 2 drugs greater than summation
Sulphonamide & Trimethoprim
Bacteristitc alone
together bactericidal
clonidie & opiate
Potentiation
1 drugh increases effect of other
NDMR - from Mag
Isobolgram
Effeects 2 drugs
Interaction /2
Fract conc - repr x y
Draw from pg158
Affinity
How avidly a drug binds to receptor
Intrinsic activity
‘efficacy’
Magnitude of effect drug produces after bound to receptor
Potency
Measure quanitiy drug needed to produce max effect
Large dose - not potent - small dose - max effect
Compare potency two drugs
Compare EC50 or ED50
EC 50 - conc drug prod spec repsonse halfway base & max
ED50
Specific response in 50% population take
Agonist
Signifcant affinity for receptor & full intrinsic activity
Bind - receptor prod max response that capable
intrisnic activity of 1
Partial agonist
Significant affinity but only partial intrinsic activity
max response never mediate
Int act 0-1
Bupenonrphine at U rec
Can act as agonist or antag - dep sitatuion
Use alone - agonist
produce some response even if not max
Also if use along a low dose true agon
If use w/ high dose true agonist - competitive antagonist - compete for receptpr - prevent full occupancy & ergo max response
Inverse agonist
Significant affinity & intrisnce activty - opposit effect to endog agonist
Antagonist
Types
Signif affinity - no intrnisic activty
bind no response - 0
Reversible
compet or non compt
Rev comp antag compete same receprot - effect of antag overcome increase dose agonist
NDMR (nic rec NMJ) & bbloq 0 com adrenaline @ b
Rev non comp - prev activation throuhg distrortion of receptor not bind same site
Cannot overcome w/ inc conc
Kewatmine 0- glut at NMDA
Rev Comp Antag & Rev Non comp
Rev comp antag compete same receprot - effect of antag overcome increase dose agonist
NDMR (nic rec NMJ) & bbloq 0 com adrenaline @ b
Rev non comp - prev activation throuhg distrortion of receptor not bind same site
Cannot overcome w/ inc conc
Kewatmine 0- glut at NMDA
Irrev antagonist
Bind irreversibly to rec or distant site
prevent binding
The agonist dose will not overcome as it is irreversible
Pehnoxybenzamine
Alpha adreno to antagonise catetchol
Competitve antagonist + Inverse agonist
Inverse agonist - exert to physiolog effect Opposit to agonist - bind w/rec
Competiv antag - no direct effect own - stop endog agonist
Dose reponse curve
Draw
Graph conc x & response Y
Hyoerbolic
Initially drug conc inc & rec occupancy increase
- response increases
Number receptor decrease - effect increase - sammler effect of response
slope flatten @ 100
ec - halfway ma & min
Log dose reponse curve
Semi log plot
log scale - dose x & response on Y
Classic sigmod shape
Steep part - approx linear - asses relationshjip easeier ed50 on steep linear part